Lithium Controlled-Release and Extended-Release Tablets and Orfadin (Nitisinone Oral Suspension)
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Orfadin (Nitisinone Oral Suspension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: nitisinone
Brand name: Orfadin, Nityr
Synonyms: Orfadin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Orfadin Suspension
- Lithium Controlled-Release and Extended-Release Tablets-Orfro
- Lithium Controlled-Release and Extended-Release Tablets-Orgaran
- Lithium Controlled-Release and Extended-Release Tablets-Orilissa
- Lithium Controlled-Release and Extended-Release Tablets-Oritavancin
- Lithium Controlled-Release and Extended-Release Tablets-Oritavancin Diphosphate
- Orfadin (Nitisinone Oral Suspension)-Lithium ER
- Orfadin (Nitisinone Oral Suspension)-Lithium Oral Solution
- Orfadin (Nitisinone Oral Suspension)-Lithium Salts
- Orfadin (Nitisinone Oral Suspension)-Lithium Syrup and Oral Solution
- Orfadin (Nitisinone Oral Suspension)-Lithobid
- Orfadin (Nitisinone Oral Suspension)-Lithostat